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Diesel exhaust and its particles (DEP) have been under scrutiny for health effects in humans. In the development of these effects
inflammation is regarded as a key process. Overall, in vitro studies report similar DEP-induced changes inmarkers of inflammation,
including cytokines and chemokines, as studies in vivo. In vitro studies suggest that soluble extracts of DEP have the greatest impact
on the expression and release of proinflammatory markers. Main DEP mediators of effects have still not been identified and are
difficult to find, as fuel and engine technology developments lead to continuously altered characteristics of emissions. Involved
mechanisms remain somewhat unclear. DEP extracts appear to comprise components that are able to activate various membrane
and cytosolic receptors.Through interactions with receptors, ion channels, and phosphorylation enzymes, molecules in the particle
extract will trigger various cell signaling pathways that may lead to the release of inflammatory markers directly or indirectly by
causing cell death. In vitro studies represent a fast and convenient systemwhichmay have implications for technology development.
Furthermore, knowledge regarding how particles elicit their effects may contribute to understanding of DEP-induced health effects
in vivo, with possible implications for identifying susceptible groups of people and effect biomarkers.
1. Introduction
Living close to heavily trafficked roads has been associated
with adverse effects on people’s health, including increased
mortality and morbidity from cardiopulmonary causes [1].
Though the proximity to dense traffic includes exposure to
noise and gasses, which may adversely affect health [1, 2],
emissions of particle matter (PM) from traffic are estimated
to have a major adverse impact on health [1, 3]. Notably,
exposure to PM has been associated with adverse effects
on the pulmonary as well as cardiovascular system [4, 5].
PM from traffic comprises road dust, vehicle particles, and
exhaust particles, which have all been linked to adverse
health outcomes [1]. However, most publications focus on the
exhaust particles.
Traditionally diesel engines have mostly been used in
heavy duty vehicles. However, according to statistics from the
European automobile manufacturers’ association (ACEA),
there has been a large increase in the percentage of newly
registered diesel passenger cars in Western Europe, from
13.8% in 1990 to 50.6% in 2010. This is an intended increase
as a means to cut CO
2
emissions from transport. However,
diesel-fuelled vehicles with pre-EURO 5 technologies or the
equivalent US standard are known for their higher PM
emissions compared to gasoline-fuelled vehicles, and will
dominate the car fleets for several years, considering the
average age of the vehicles in operation. As a result of the
significant contribution of PM emissions from diesel vehicles
for the total concentration of PM in ambient air, extensive
research on effects of diesel engine exhaust (DEE) and diesel
exhaust particles (DEP) has been carried out.
Inflammation is considered a key step in the development
of health effects associated with PM exposure [6–9]. Acti-
vated immune cells including neutrophils and macrophages
will release cytokines, reactive oxygen species (ROS), lipid
mediators, and toxic proteases, which may further amplify
and contribute to any DEP-induced epithelial damage. A
further increased release of pro-inflammatory mediators
from the epithelium and/or induced epithelial cell death may
augment as well as prolong the inflammatory reactions, and
ultimately result in chronic inflammation if the exposure
persists. Furthermore, the increased oxidative stress caused
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by activated immune cells, may also contribute to DEP-
induced DNA damage, and mutations [10]. Notably, chronic
inflammation is also a central part of cancer development [11].
In addition to promoting the development of lung diseases,
airway inflammation may be a cardiovascular risk factor.
Evidence suggests that inflammation in the lung may lead to
systemic inflammation, whichmay increase the susceptibility
to acute cardiovascular disease [12–14].
Cell culturemodels in vitrohave been used to characterize
various toxic effects of DEP including DNA damage, effects
on cell proliferation, release of cytokines and chemokines,
differentiation and/or capacity of immune cells to defend
against infections cytotoxicity (cellular differentiation), and
cytotoxicity. Furthermore, such models have been used
to investigate effects of various types of DEP and DEP-
components, as well as to studymore detailed mechanisms of
effect. Since DEPmay deposit at various places in the airways
[15], different lung epithelial cells as well as immune cells and
combinations have been used.
Many factors influence the chemical and physical prop-
erties of collected DEP; among them are engine technol-
ogy, fuel, load, temperature and filtration devices. Thus, a
range of different DEP samples with varying composition
have been studied. Some studies have also investigated the
effect of engine and fuel interventions (Table 1). This paper
summarises in vitro studies of pro- and anti-inflammatory-
and allergy- linked responses of lung cells after exposure
to different DEP and associated compounds. Focus will be
on mechanisms involved in pro-inflammatory effects. This
knowledge will contribute to the understanding of DEP-
induced health effects in vivo and represent a fast and
convenient system for technology development.
2. Expression and Release of
Cytokines and Chemokines
Inflammatory reactions in vivo involve the production and
release of a range of signalling molecules such as cytok-
ines, chemokines, and leukotrienes/prostaglandins and adhe-
sion molecules. These molecules operate in a complex net-
work between epithelial cells and immune cells includ-
ing macrophages, neutrophils, eosinophils, dendritic cells,
and Th-cells [6, 44]. Depending on the cytokines and/or
chemokines released, different classes of immune cells will
be recruited and affect the outcome of the inflamma-
tory response. In mild to moderate allergic asthma related
responses eosinophils are the predominant inflammatory
cells, whereas episodes of acute exacerbation of asthma tend
to be driven by neutrophilic inflammation [45]. Neutrophils
are also believed to be the more important for the devel-
opment of chronic obstructive pulmonary disease (COPD),
because of their ability to release elastase which mediates tis-
sue destruction [46]. Eosinophils express CCR3-chemokine
receptors and are primarily activated and recruited by
chemokines CCL-chemokines such as CCL5/-7/-11/-16/-24
and -26, whereas neutrophils express CXCR1 and -2 receptors
and are primarily activated by CXCL-chemokines including
CXCL1-3 and -5-8 [47]. Similarly, other classes of immune
cells such as dendritic cells, basophils, B-cells, and various
T cells express relatively specific sets of chemokine receptors
allowing for targeted activation of different types of immune
responses.
At a cellular level, the onset of pro-inflammatory reac-
tions tends to start by release of early-responding cytokines
such as interleukin (IL)-1𝛼 and-𝛽 and tumor necrosis factor
(TNF)-𝛼. IL-1𝛼/-𝛽 and TNF-𝛼 tend to be expressed as
inactive proforms in resting cells and may be rapidly cleaved
and released without requiring activation of the transcrip-
tional machinery. This enables an immediate response upon
encounters with inhaled pathogens or xenobiotics. IL-1𝛼/-
𝛽 and TNF-𝛼 subsequently regulate the expression of a
variety of secondary cytokines and chemokines, including
IL-6 and CXCL8 (IL-8). However, secondary cytokines may
also be activated more directly by DEP (independently of IL-
1𝛼/-𝛽 and TNF-𝛼) through activation of pro-inflammatory
signalling pathways within the cells.
The release of IL-1𝛽 is tightly controlled, which seems to
requires a dual pathway activation process involving tran-
scriptional activation of the IL-1𝛽 gene leading to formation
of pro-IL-1𝛽 and activation of the NALP3 inflammasome
system.This leads to cleavage of the pro-form and subsequent
release of active IL-1𝛽 [48]. Increased expression of pro-
IL-1𝛽 is often found after exposure to lipopolysaccharide
(LPS), an inflammatory Toll-like receptor (TLR) agonist
from bacterial walls. NAPL3 on the other hand responds
to so-called danger-associated molecular patterns (DAMPs)
released during cellular necrosis, such as uric acid crystals
[49]. However, DAMPs and other NALP3 activators do not
seem to induce formation of pro-IL-1𝛽. Thus priming with
LPS is often required for DAMPs to induce cellular IL-1𝛽
release. Interestingly, in the absence of LPS, an increased
expression of IL-1𝛽 in alveolar epithelial lung cells (A549)
was found in an air-liquid exposure system to freshly gener-
ated DEP [42]. Also, in THP-1 monocytes NIST-2975 DEP
induced an increase in IL-1𝛽 release, independently of the
presence of LPS [20]. In a coculture of BEAS-2B cells and
primary human monocytes, NIST 2975 DEP enhanced the
cytokine release of IL-8 after pre-treatment with LPS. [26].
However, this response does not seem to occur through a
“classic” activation of the NALP3-inflammasome complex.
NIST 2975 DEP is also reported to reduce an IL-1𝛽-induced
IL-8 response in theBEAS-2B andmonocytes co-culture [26].
Furthermore, central elements of the NALP3-inflammasome
did not seem to be needed in responses to DEP in transgenic
mice [50].
TNF-𝛼 is expressed as a membrane bound proform that
is released upon cleavage by the metalloprotease TNF-𝛼
converting enzyme (TACE), also known as ADAM-17 [51].
Thus, DEP may induce pro-inflammatory effects depen-
dent on TACE-mediated TNF-𝛼 cleavage. DEP have been
reported to induce TNF-𝛼 responses in primary monocyte-
derived macrophages, and cytokine responses in endothe-
lial cells exposed to conditioned media from DEP-exposed
macrophages was suppressed by TNF-𝛼-inhibition [52].
Diesel-enriched PM has also been found to induce TNF-𝛼
in monocyte-derived dendritic cells [53]. In contrast, studies
in human and murine alveolar macrophages have reported
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Table 1: Origin of diesel particles used in the different studies, test systems, concentrations and effects on different end-points. The arrows
give a rough indication of the magnitude of effects judged from the results presented (small: ↑; moderate: ↑↑; strong ↑↑↑).
Diesel type Test system Concentrations Endpoints Citation
Heavy duty machine
NIST 1650 Cell-free Not relevant ROS (malondialdehyde) ↑↑ Ball et al. [16]
Heavy duty machine
NIST 1650
Bronchial epithelial cells (16HBE
cell line),
Primary human nasal epithelial
cells
10–30𝜇g/cm2
ROS-formation
(DCF-fluoroscence) ↑↑, CYPIAI
mRNA and EROD-activity ↑↑;
NADPH quinone
oxidodreductase-1 mRNA ↑↑;
translocation of transcription
factor Nrf2 ↑↑
Baulig et al., [17, 18]
Heavy duty machine
NIST 1650
16-HBE (bronchial epithelial
cells) 10𝜇g/cm2
GM-CSF ↑↑, NF𝜅-B activity ↑↑,
CYP1A1 mRNA ↑↑,
Phosphorylation of MAPK Erk
and p38 ↑↑
Bonvallot et al.,
[19]
Heavy duty machine
NIST 1650
THP-1 monocyte and A549
epithelial cell co-culture 10–40𝜇g/cm
2 IL-6 ↑; IL-8 ↑; TNF𝛼 Kocbach et al., [20]
Heavy duty machine
NIST 1650 A549 epithelial cells 0.1 to 20 ppm IL-8 ↑; CRP ↑ Patel et al., [21]
Heavy duty machine
NIST 1650
RAWmonocyte/macrophages 5–20𝜇g/mL NO-production ↑↑ Saxena et al., [22]
Heavy duty machine
NIST 1650
BEAS-2B, (bronchial epithelial
cells) ∼4–60 𝜇g/cm
2 Increased cytotoxicity Totlandsdal et al.,[23]
Forklift
NIST 2975 Cell-free, Not relevant ROS (malondialdehyde) ↑ Ball et al. [16]
Forklift
NIST 2975 Primary human epithelial cells 50𝜇g/mL
Phosphorylation of Stat3,
EGF-receptor ↑↑ Cao et al., [24]
Forklift
NIST 2975
BEAS-2B Bronchial epithelial
cells 10𝜇g/cm
2 STAT3; src; EGFR necessary for
p21 ↑↑; inhibition of proliferation Cao et al., [25]
Forklift
NIST 2975
BEAS-2B Bronchial epithelial
cells + primary monocytes 50𝜇g/mL IL-1
Chaudhuri et al.,
[26]
Forklift
NIST 2975
HEK-293 epidermal cells,
primary mouse neurons 77–770 𝜇g/mL TRPA-1 activation ↑
Deering-Rice et al.,
[27]
Forklift
NIST 2975
16-HBE, monocytes, dendritic
cells, triple co-culture
125 𝜇g/mL (cells
on insert)
Reduction and altered
distribution of occluding, minor
effect in epithelial cells, stronger
in other cell types
Lehmann et al.,
[28]
Forklift
NIST 2975 A549 and NCI-H292 cells 5–10 𝜇g/cm
2 MMP-1 Amara et al., [29]
Forklift
NIST 2975 Primary murine tracheal cells 25 𝜇g/cm
2
Small effects on LDH, HO-1
Alveolar lung cell line
GSH/GSSG ratio
Manzo et al., [30]
Forklift
NIST 2975
Primary human macrophages
Suspension culture, 100𝜇g/mL
No significant increase in TNF or
IL-8; DEP reduced cytokine
release induced by LPS
Sawyer et al., [31]
Forklift
NIST 2975
BEAS-2B (bronchial epithelial
cells)
Only extracts
tested IL.6 ↑; IL-8 ↑ Swanson et al., [32]
Forklift
NIST 2975
BEAS-2B cells (bronchial
epithelial cells), HAEC cells 10𝜇g/cm
2 IL-8 mRNA ↑↑,
N-DEP effect NF𝜅B dependent Tal et al., [33]
NIST, not specified A549 epithelial cells and primaryrat airway epithelial cells 20 𝜇g/cm
2 Transepithelial conductance ↑
Occluding ↓
Caraballo et al.,
[34]
C-DEP, EPA diesel
(2005) Primary human epithelial cells 50𝜇g/mL Phosphorylation of Stat3 ↑↑↑ Cao et al., [24]
A-DEP, diesel from
Sagai et al., [35]
BEAS-2B (bronchial epithelial
cells) 10𝜇g/cm
2 IL-8 mRNA ↑↑↑ Tal et al., [33]
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Table 1: Continued.
Diesel type Test system Concentrations Endpoints Citation
A-DEP, diesel from
Sagai et al., [35]
BEAS-2B (bronchial epithelial
cells) 5–50 𝜇g/mL HSP70 ↑↑ at 10𝜇g/mL Jung et al., [36]
2.7 L Isuzu diesel;
A-DEP diesel from
Sagai et al., [35]
BEAS-2B (bronchial epithelial
cells) and primary peripheral
airway cells
5 and 25𝜇g/mL IL-8 ↑↑ Kawasaki et al.,[37]
2.7 L Isuzu diesel;
A-DEP before year
2000
BEAS-2B (bronchial epithelial
cells) 5–100 𝜇g/mL
IL-8 ↑↑,
GM-CSF ↑↑,
Depending on NF𝜅B, reduced by
NAC
Takizawa et al.,
[38, 39]
2.7 L Isuzu diesel;
A-DEP before year
2000
BEAS-2B (bronchial epithelial
cells) 5–100 𝜇g/mL
IL-8 ↑↑, RANTES ↑↑; dependent
on p38, reduced by NAC
Hashimoto et al.,
[40]
Deutz unloaded 2.2 L;
EURO 4 (2009)
BEAS-2B (bronchial epithelial
cells) ∼4–60 𝜇g/cm
2
IL-6 ↑↑; IL-8 ↑↑;
CYP1A1 ↑↑↑ (at 0.004 𝜇g/cm2);
COX-2 ↑↑↑; p38 ↑ and NF𝜅B ↑
Totlandsdal et al.,
[23]
DEPA (from EPA) Primary murine tracheal cells 5–200 𝜇g/cm
2 LDH ↑ at 100𝜇g/cm2
Alveolar lung cell line HO-1 ↑↑ Manzo et al., [30]
1.6 L Volkswagen
diesel; from EPA
(1992)
Primary human bronchial
epithelial cells; human primary
monocytes differentiated to
dendritic cells;
3𝜇g/cm2
Epithelial cells TSLP ↑↑
Dendritic cells
OX40L ↑↑; Bleck et al., [41]
Heavy duty 9.2 L;
DEP freshly generated
A549 epithelial cells, Air-liquid
interface exposure
Low 0.1mg/m3
High 0.8mg/m3
IL-1𝛽 only at one conc of high
NO2, reduced viability
Tsukue et al., [42]
2.2 L Honda EURO 4
machine DEP + rape
seed biodiesel (±DPF)
BEAS-2B (bronchial epithelial
cells) ∼6 to 200𝜇g/mL
IL-6
Most effect in 𝜇g/mL
B50 DPF≫ B0DPF > B50 > B0
Gerlofs-Nijland et
al., submitted
2.2 L Honda EURO 4
machine, Golf.
Corolla cars DPF,
diesel biodiesel
Cell-free Not relevant Correlation of DTT consumptionwith EC/Water insoluble OC/OC Ka et al., [43]
US 2004 machine
(black smoker)
HEK-293 epidermal cells,
primary mouse neurons 77–770 𝜇g/mL TRPA-1 activation ↑↑
Deering-Rice et al.,
[27]
Soy bean biodiesel
2005
BEAS-2B (bronchial epithelial
cells)
Only extracts
tested
Stronger effects of biodiesel (soy
bean) Swanson et al., [32]
that DEP rather suppress TNF-𝛼 responses [54–56]. To the
best of our knowledge, no effects of DEP or DEP-extracts
on TNF-𝛼 response have been reported from pulmonary
epithelial cells. However, DEP have been found to induce
TNF-𝛼 responses in middle-ear epithelial cells [57], but not
in human keratinocytes [58]. In total, TNF-𝛼-release does not
seem to be a prerequisite forDEP to induce pro-inflammatory
responses in vitro. In line with this, in vivo studies with TNF-
𝛼 knock-out mice suggest that DEP-induced inflammation is
triggered independently of TNF-𝛼 [59].
Many in vitro studies on lung epithelial cells have reported
that DEP induce the release of a number of cytokines and
chemokines that are involved in both innate and/or adaptive
immunity inflammatory responses [60]. Innate immunity
cytokines such as IL-6 and IL-8 have often been included
in investigations of DEP effects. In studies with BEAS-2B
bronchial epithelial lung cells DEP from a pre-year-2000
engine increased the release of chemokines such as IL-8 [33,
38]. In a comparison of different DEP, the older DEPs from
Japan [35] and the NIST 2975 were considerably more potent
than the more recently produced DEP from EPA (Table 1).
However, not all studies report increased IL-8 levels after
DEP exposure, despite increased IL-8 RNA levels [23]. In
a broader analysis on the mRNA level of EURO-4 DEP-
induced cytokines inBEAS-2B cells, Totlandsdal and cowork-
ers observed increased levels of CCL5 (RANTES), CXCL10,
and IL-1𝛽 among others, in addition to high levels of IL-6
and IL-8 [23]. However, only the last two reached statistical
significance. Increased RANTES after DEP-exposure (pre-
year-2000 engine) has also been reported by Hashimoto and
co-workers [40].
Thymic stromal lymphopoietin (TSLP) is an an IL-7-
like cytokine which has received considerable attention as
a possible “master-switch” in allergic disease. TSLP from
epithelial barrier surfaces suppress p40 and induce OX40L
expression by dendritic cells (DCs), which suppress Th1 and
promote Th2 responses, respectively [61]. Exposure to pre-
year-2000 DEP has been shown to induce TSLP release from
human bronchial epithelial cells (BEAS-2B) subsequently
leading to maturation and polarisation of DCs [41]. The
DEP-dependent release of TSLP from the epithelial cells also
caused the DCs to express OX40L ligand and Jagged-1 [62].
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Thus effects of DEP on epithelial lung cells may promote the
induction of Th2 responses, often associated with adaptive
immunity and allergic asthma.The ability ofDEP to stimulate
adaptive immune responses has been corroborated by a study
in transgenic mice [63].
An increase in granulocyte macrophage colony-stim-
ulating factor (GM-CSF), that stimulates monocyte multi-
plication, has also been observed after DEP exposure [17,
38]. DEP-enriched particulate matter sampled in a tunnel
stimulated cytokine release (IL-12, TNF-𝛼, IL-6, and inter-
feron (IFN)-𝛾) from primary monocyte-derived dendritic
cells [53]. This indicates that other cell types can contribute
to a pro-inflammatory pattern of cytokines and chemokines
in concert with macrophages and epithelial cells. Moreover,
conditioned medium from macrophages exposed to DEP
(NIST 2975) stimulated primary human endothelial cells
(HUVEC) to release cytokines and chemokines through a
TNF-𝛼 dependent mechanism, indicating that pulmonary
inflammatory markers may influence systemic cells [52].
Similar observations have also been reported from studies
with carbon black particles [64].
3. Other Inflammation-Related Proteins
In addition to cytokines and chemokines, a variety of other
signalling molecules are involved in the orchestration of
inflammatory responses. ICAM-1 plays a critical role in the
adhesion of inflammatory cells to reach the place of an
inflammatory response. BEAS-2B cells have been shown to
increase expression of this molecule on their surfaces upon
exposure to pre-year-2000 DEP [39].
Epithelial cells can form a tight monolayer that presents
a barrier to prevent the external agents from entering the
circulation. NIST DEP can increase transepithelial electrical
conductance and loosening of the tight junctions, thus
increasing the possibility of leakage of proteins and per-
haps particles to the vascular system [34]. In a triple co-
culture model (bronchial epithelial 16HBe140 cells, mono-
cyte derived macrophages, and dendritic cells) Lehmann
et al. observed that NIST 2975 modulated occludin RNA
levels which may have implications for tight junction func-
tion. However the effect was only observed at the highest
concentration [28]. In this connection, it is interesting to
note that NIST 2975 DEP have been reported to increase
the release of metalloproteinase MMP-1 from human lung
epithelial cells (A549 and NCI-H292). MMP-1 is involved in
the degradation of collagen and can thus damage the lung
epithelial barrier, probably involving an oxidativemechanism
that includes NOX4 [29]. These findings suggest that DEP
not only can induce pro-inflammatory responses, but also
contribute to structural changes with inflammatory implica-
tions.
Prostaglandins function as attractants of inflammatory
cells. Studies have found that EURO-4DEP increased the lev-
els of COX-2 in BEAS-2B cells, a key enzyme in prostaglandin
production [23]. This response was also observed with
three different DEP (Table 1). DEP have also been reported
to enhance COX-2- and prostaglandin E2-responses in
monocyte-derived macrophages primed with TLR2 and -4
ligands [65].
Heat shock proteins HSP70 and HSP40 and two other
proteins involved in the protein unfolding response were
induced after exposure of BEAS-2B cells to pre-year-
2000DEP extracts. This response was accompanied by an
increase in IL-6 and IL-8 and possibly related toDEP-induced
oxidative stress [36].
Many studies have reported that DEP induce the expres-
sion of phase I and II xenobiotic metabolising enzymes
through activation of the AhR andNrf2 transcription factors,
respectively [18, 23, 66–68]. Thus, AhR- and Nrf2-regulated
gene expression may represent indirect biomarkers of expo-
sure to DEP. Furthermore, phase I enzymes are involved
in metabolic activation of various xenobiotics to reactive
electrophilic metabolites including ROS, possible trigger-
ing molecules of inflammatory reactions following DEP-
exposure. This may occur not only directly with regard to
triggering of cytokines/chemokine release, but also indirectly
via increased cellular toxicity and release of inflammatory
DAMPmolecules.Thus, changes in the balance between acti-
vation and detoxification of the metabolism of xenobiotic in
the lung cellsmay have important inflammatory implications.
The phase I enzyme CYP 1A1 is reported to be induced
at concentrations of about 0.1 𝜇g/mL or 0.004𝜇g/cm2 [23].
However, the increase in CYP1A1 was greatly reduced at
higher concentrations, when inflammatory cytokines and
chemokines were prominent [23]. The data indicate a recip-
rocal relationship between theAhR/Arnt-dependent CYP1A1
induction and cytokine production, apparently because AhR
has an inhibitory role in the control of inflammation [69–
71]. Also the stimulation of the expression of phase II
detoxification enzymes by DEP extracts seemed to reduce the
cytokine response [72].
4. Particle Considerations
There seems to be obvious differences in the composition
of DEP of different age and source. Some older DEP-prep-
arations are apparently less potent than some newer ones
(e.g., EURO 4 DEP), although these differences do not seem
to correlate with “classic”, carcinogenic polycyclic aromatic
hydrocarbons (PAH) content (unpublished results from our
lab). DEP typically consists of agglomerates of primary
carbon particles 15–30 nm in diameter and nucleation mode
particles of condensed hydrocarbons and sulphate [73]. How-
ever, differences in engine and emission-cleansing technolo-
gies may affect the ratio of these two main particle fractions
in diesel exhaust emissions and has also considerable impact
on the amount and composition of chemicals adhered to the
surface of the emitted DEP [74].
4.1. Importance of Soluble Organic Fraction of DEP. In gen-
eral, both the particulate as well as the organic components
of DEP are of importance for DEP-induced effects [75–77].
However, some in vitro studies comparing effects induced by
organic DEP extracts and corresponding residual particles
(subjected to extraction) have demonstrated that the organic
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fractions of DEP may be of particular importance for pro-
inflammatory responses [19, 78, 79]. It is yet unclear to
what extent these responses to the organic extracts could be
attributed to the presence of specific groups of compounds.
Recent studies indicate that polar organic extracts of PM
were found to induce cytotoxicity and IL-6 responses in
BEAS-2B cells, while nonpolar organic PM-extracts had no
apparent effect [80]. In accordance with this, observations
from our lab indicate that compounds eluting in the polar
fraction of methanol-extracts of DEP may be of particular
importance. Notably, the effects of the polar fraction could
not be attributed to identified PAH and PAH-derivatives in
the extract (Totlandsdal et al., unpublished results).
Suppressive effects of DEP and DEP organic extracts on
various immune responses have also been reported. More
specifically, DEP and DEP organic extracts have been found
to reduce alveolar macrophage function as demonstrated by
reduced production of cytokines (IL-1, TNF-𝛼) and ROS in
response to a variety of biological agents (LPS, interferon-𝛾
and bacteria) [54–56, 76]. Different fractions of organic DEP-
extracts have been tested for the ability to suppress NO pro-
duction from BCG-stimulated macrophages [22]. The polar
fractions seemedmore inhibitory than the less polar fractions
[22]. Recent observations from our lab also suggest that high-
polar organic DEP-extracts supress IL-8 responses in BEAS-
2B cells, despite stimulating IL-6 responses (Totlandsdal et al.
unpublished results). Similar findings have been reported for
polar extracts of ambient PM [80]. Furthermore, it has been
shown that the organic content of DEP, which was in the rank
order NIST 2975 < compressor diesel (EPA) < automobile
diesel, did not correlate with the immune responses [33].
Thus, obviously there are specific compounds of the organic
fraction of DEP, differing with regard to DEP-age, -fuel type,
and/or engine, that are of particular importance for cellular
responses.
With respect to allergy-related responses there are to our
knowledge no in vitro studies that investigate the difference
between DEP and corresponding DEP organic extracts and
residual DEP. However, a study in mice has indicated that
the organic fraction rather than the washed particles may be
responsible for the enhancement of allergy-related responses,
although a role for the solid core of the carbonaceous particles
could not be excluded [81].
4.2. Biodiesel. A major reason for the interest in biodiesel
fuel has been environmental benefits in terms of decreased
global warming impacts and reduced emissions. Increased
use of biodiesel in Europe represents an important step
for the European Union in order to meet its emission
reduction targets and a variety of biofuels are already being
introduced into wider use in heavy-duty diesel engines such
as those installed in buses and trucks in cities. However,
according to a previous review, biodiesel exhaust emission
has been extensively characterized under field and laboratory
conditions, but there have been limited studies on the effects
of biodiesel exhaust in biologic systems [82].
More recently, it has been demonstrated by human
inhalation studies that biodiesel (soy bean ethyl esters,
SEE: B50 and B100 (50 and 100% biodiesel, resp.)) was equally
or more toxic than fossil diesel in promoting cardiovascular
alterations as well as pulmonary and systemic inflammation
[83]. Coherent with the inflammatory potential of biodiesel
demonstrated in this in vivo study, recent in vitro work from
our lab demonstrates a greater toxic and pro-inflammatory
capacity in human bronchial epithelial BEAS-2B cells of
DEP with biodiesel (rape seed oil methyl esters, RME) than
ordinary DEP, especially in the presence of a diesel particle
filter (Gerlofs-Nijland et al. unpublished results). Moreover,
extracts of biodiesel (blend of SEE and SME) have been
reported to induce cytokine responses in BEAS-2B cells
at lower concentrations than extracts of petroleum diesel
[32]. In contrast, Jalava and colleagues [84] observed that
biodiesel DEP were as potent as ordinary DEP, or less potent,
depending on the end point (pro-inflammatory response,
cell death, DNA damage, or oxidative potential in a mouse
macrophage-like cell line (RAW264.7)). In a separate study,
only pure fossil diesel and not B20-blends of RME or animal
fat methyl esters (AFME) was found to induce ICAM-1 and
VCAM-1 expression in primary human umbilical cord cells
(HUVECs), and none of the tested DEPs affected IL-8 and
CCL2 expression significantly in the human monocytic cell
line, THP-1 [85]. Whether these apparent discrepancies in
the pro-inflammatory potential of biodiesel are due to cell
specific effects or differences in the chemical composition of
the DEPs used in the different studies remains to be clarified.
Importantly, as pointed out by Brito and colleagues [83],
biodiesel may from a commercial point of view be considered
as a cleaner, less toxic, and more biodegradable fuel. Thus,
the above findings clearly highlight the importance of further
studies to elucidate how and to what extent biodiesel fuels
affect pro-inflammatory compared to conventional fossil fuel.
5. Biological Mechanisms of DEP-Induced
Proinflammatory and Cytotoxic Effects
The genotoxicity of DEP is to a large extent considered to
be due to chemicals found in the organic DEP-extracts, such
as PAH. In particular, nitro-PAH seem to be important for
the mutagenicity of DEP [86, 87]. Also the pro-inflammatory
DEP-effects seem mainly to be mediated by constituents
in organic DEP-extracts [19, 37, 78, 79]. Most interestingly,
DEP with different amount of soluble organic materials
may induce IL-8 responses through different mechanisms
[33]. DEP with high organic content induced IL-8 through
activation of AP-1, while DEP with low organic content
induced IL-8 through nuclear factor (NF)-𝜅B. The reason
for this difference is unclear, but since activation of the
AhR may lead to suppression of NF-𝜅B signaling [69, 71],
it is conceivable that the effects could be related to a higher
content of AhR-activating compounds in the organic-rich
DEP. In any case, the observation is of particular importance
as it underscores that DEP from different sources may induce
inflammation through different mechanisms, triggered by
different DEP-constituents. It should also be considered that
even with a single-source DEP it seems unlikely, given the
multitude of chemical components adhered to the particle
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surface, that there exists a simple mechanism explaining
the cellular effects. Moreover, as the concentration-effect
course of toxicity by different DEP-constituents most prob-
ably differs, the complexity of DEP-induced toxicity is also
likely to increase by increasing concentrations, as more and
more DEP-constituents enter toxic levels. As a consequence,
mechanisms of effects observed at high DEP-concentrations
in in vitro studies may not necessarily be directly relevant
for the effects of low-level DEP-concentrations in real-life
exposure.
As within most fields of particle toxicity, oxidative stress
is considered a main mechanism of DEP-induced toxicity
and inflammation [7, 88, 89]. DEP-induced ROS-formation
may activate redox-sensitive transcription factors involved
in regulation of pro-inflammatory genes, such as NF-𝜅B
and Nrf2 [18, 19]. ROS may interfere with various cell
signaling pathways by inhibition of phosphatases through
binding/oxidation of important thiol groups subsequently
leading to increased phosphorylation/activation of protein
kinases. In line with this, genotype variation in antioxidant
enzymes, such as glutathione-s-transferases (GSTs), has been
associated with susceptibility towards DEP-induced allergic
inflammation in humans [90]. However, since GSTs are phase
II metabolizing enzymes, also involved in detoxification of
organic chemicals present in DEP, it cannot be excluded that
the protective role of GSTs in DEP-induced inflammation
extends beyond ROS-scavenging.
Direct ROS formation by DEP may arise from enzymatic
metabolism of organic compounds such as PAH [18, 91].
However, several studies show that DEP also exert oxidative
effects in acellularmodel systems. In a study ofDEPproduced
by 4 different engine technologies (Euro1 to Euro 4), the
antioxidant (DTT) consumption as a measure of oxidative
capacity showed a correlation with the content of elemental
carbon, water-insoluble carbon, and organic carbon [43].
Moreover, the two different reference-DEP, NIST 1650 and
2975, have been found to exhibit different oxidative capacity
in cell free systems, possibly due to difference in chemical
composition [16]. Furthermore, Mudway and colleagues [92]
showed that DEP depleted lung lining fluid antioxidant
levels in vitro. In contrast, a comparable effect of DEP
was not observed in the airways of healthy subjects; and
in a cell culture model in vitro the ratio of oxidised to
nonoxidised glutathione did not change significantly after
exposure to two different diesels, DEPa and NIST 2975 [30].
Thus, possibly the antioxidant defence in the lung lining
fluid [92] and lung epithelial cells of healthy individuals
are capable of dealing with the oxidative challenge posed
by DEP at environmentally relevant concentrations. In a
recent study of DEP from different fuel types, produced in
the presence or absence of particle filter technology (PDF-
treatment), we did not observe any correlation between
a cellular DEP-induced ROS formation and DEP-induced
cytokine responses in human bronchial epithelial BEAS-
2B cells (Gerlofs-Nijland et al. unpublished results). This
observation resembles previous results of studies on mineral
particles showing no clear correlation between acellular ROS-
formation and pro-inflammatory responses in in vitro cell
culture models [93, 94].
DEP may also stimulate cellular generation of ROS as
well as reactive nitrogen species (RNS) through activation
of nitric oxide synthetase (iNOS) [29, 95, 96]. Moreover,
DEP-induced MMP-1 responses in human alveolar type-2
like A549 cells appeared to be dependent on activation of
cellular ROS-formation by the NADPH-oxidase analogue
NOX4 [29]. NADPH-oxidase-mediated ROS formation also
seems to regulate DEP-induced TNF-𝛼 responses in iso-
lated rat brain capillaries [97], and toxicity of DEP in
dopaminergic neurons [98]. Moreover, the DEP-component
1,2-naphthoquinone (1,2-NQ) was reported to induce IL-
8 responses in human bronchial epithelial BEAS-2B cells,
through mitochondrial H
2
O
2
-production [99]. Thus, it is
conceivable that much of the reported suppressive effects of
antioxidants on DEP-induced pro-inflammatory responses
may be due to interference with DEP-induced cellular ROS-
generation, rather than the direct particle-derived ROS pro-
duction observed in acellular systems. If this is the case,
oxidative stress should be considered a cellular response to
DEP exposure and not a direct DEP property. However,
findings obtained by use of antioxidants need to be inter-
preted with caution. While antioxidants may attenuate DEP-
induced inflammation, the role of oxidative stress in cellular
responses is inherently difficult to interpret. Antioxidants like
N-acetyl cysteine (NAC) may also detoxify other reactive
electrophilic DEP-constituents that potentially could trigger
inflammatory reactions. Furthermore, ROS is an important
and natural second messenger in most signaling pathways
[100–102]. Thus, use of antioxidants is likely to interfere
with a variety of cellular responses irrespective of oxidative
stress. Few, if any, studies using antioxidants to assess the role
of oxidative stress in particle induced effects have included
proper controls to clarify these issues. It has also been pointed
out that in vitro ROS-formation may have limited value in
predicting pathological effects, because almost all particles
elicit oxidative stress in cells, given a sufficient concentration
[103]. Finally, oxidative stress alone may not be sufficient to
induce pro-inflammatory responses in lung cells [104, 105],
thus other and/or additional mechanisms are likely involved
in DEP-induced inflammation.
Of particular interest, recent studies show that pre-year-
2000 DEP may induce Ca2+-signaling through activation
of transient receptor potential (TRP) cation-channels in
primary and transformed human bronchial epithelial cells
(NHBE and BEAS-2B cells). Li and colleagues [106] have
shown that DEP triggered Ca2+-influx through proteinase-
activated receptor-2 (PAR-2) mediated activation of TRPV4
channels on the surface of human bronchial epithelial cells
leading to increased expression of matrix metalloproteinase-
1 (MMP-1). Ca2+-signaling appears to be central to IL-8
responses in bronchial epithelial cells induced by multiple
compounds found in ambient air [107]. Therefore, it seems
likely that DEP-induced PAR-2/TRPV4-activation is not
restricted to MMP-1 regulation, but also involved in cytokine
responses. In support of this, recent results from our lab
show that silencing of PAR-2 by siRNA attenuated DEP-
induced IL-6 responses in bronchial epithelial BEAS-2B cells
(Øvrevik et al., unpublished results). Whether DEP activates
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PAR-2 receptors directly remains to be clarified. However, in
line with previous studies on DEP-induced inflammation the
effects appeared to be due to the soluble organic fraction of
the particles [106]. These authors also showed that a TRPV4
polymorphism (TRPV4P19S) associated with increased sus-
ceptibility to COPD significantly enhanced DEP-induced
Ca2+-signaling and MMP-1 responses, thus providing a pos-
sible link betweenCOPDpathogenesis andDEP-exposure. In
parallel to these observations, Deering-Rice and co-workers
[27] found that DEP (black smoker, Table 1) induced Ca2+-
signaling by activating TRPA1 receptors in sensory nerve
cells. This effect was attributed to electrophilic components
of DEP, including various aldehydes and quinones [27]. In
further support of these findings, the DEP-component 1,2-
NQ has been found to activate TRPV1 (vanilloid receptor-
1) in guinea pig trachea [108]. However, this study suggests
that TRPV1was indirectly activated by 1,2-NQ through trans-
activation of protein tyrosine kinases such as the epidermal
growth factor receptor (EGFR).
It is interesting to note that cellular signaling through
RAGE (receptors for advanced glycation end-products) was
suggested to have a role in DEP-induced NF-𝜅B-activation
and chemokine responses (MCP-1 and CINC-1) in a type-
I-like epithelial cell line (R3/1) [109]. In line with this,
DEP-exposure also enhanced RAGE-expression in R3/1 cells
and primary human small airway epithelial cells (SAECs),
possibly providing a positive feedback mechanism for DEP-
induced inflammation [109]. However, as with the studies on
PAR-2 and TRP-channels, it is still unclear whether DEP acti-
vated RAGE directly or whether DEP or DEP-components
caused formation of RAGE-ligands in the exposed cells.
Studies also suggest that DEP exposure activates EGFR-
signaling [24, 107, 110, 111]. Of notice, the EGFR does not
seem to be a direct target of DEP or DEP-components, but
is more likely a downstream response to some DEP-triggered
effect. Activation of EGFR-signaling through cleavage and
release of membrane bound transforming growth factor
(TGF-𝛼) by themetalloproteinase TNF-𝛼 converting enzyme
(TACE or ADAM17) seems to be a universal mechanisms
of IL-8 regulation in airway epithelial cells by multiple
endogenous and exogenous compounds, including DEP and
various air pollution components [107, 112, 113]. In coherence
with reported in vitro effects increased EGFR-expression
and activation have been observed in biopsies of bronchial
epithelium from volunteers exposed to freshly generated
DEP [114]. Moreover, TACE and EGFR are overexpressed in
pulmonary epithelium of asthmatics and COPD patients and
this correlates with increased expression of IL-8, which is a
key activator of neutrophils [115]. Thus, increased TACE and
EGFR-expression may be important susceptibility factors for
neutrophilic inflammation by air pollutants.
Considerable progress has been made to elucidate the
mechanisms ofDEP-induced inflammation, beyond themere
oxidative stress effects. Whether any of the above mentioned
receptors are direct targets of DEP or organic chemicals from
DEP remains to be clarified. However, depending on the
further research, these receptors may turn out as important
susceptibility factors for adverse effects of DEP-exposure.
Such knowledge may also substantiate any possible role of
biomarkers of effect as measured by gene-array. Another
important aspect to consider is that if DEP-induced pro-
inflammatory responses are regulated by different cell surface
receptors, this is likely to give rise to cell specific effects,
since receptor expression may be highly cell-type dependent.
Similarly, expression of metabolizing enzymes involved in
bioactivation or ROS-formation from adhered hydrocarbons
may also vary between different cell-types and affect the
outcome of exposure. It is conceivable that this may explain
apparent discrepancies in effects obtained by different in
vitromodels, such as the reported biodiesel effects discussed
above. For the same reason, care should be taken when
interpreting the importance of results obtained by a single cell
model.
6. Challenges and Concluding Remarks
Diesel engine exhaust represents a complex and variable air
pollution mixture, of which the physicochemical character-
istics are highly dependent on the fuel used and the type of
engine [43, 116]. Recently, Hesterberg and colleagues have
stressed this important issue, by questioning the relevance of
certain samples or exhaust exposures that currently are used
in experimental studies, for risk-assessment of particulate
matter from new technology diesel exhaust [74]. As shown in
Table 1, a large proportion of the in vitro studies have used the
standard reference diesel material from the National Institute
of Standards and Technology (NIST, USA), which were
collected from a fork lift truck several years ago. Although
a thoroughly characterised material may be very useful for
investigating the role of the physicochemical composition for
the effects, one may question whether it is time to produce
and agree on a commercial reference diesel sample which is
more representative to current diesel emissions.
In vitro studies represent a fast and convenient system
which may have implications for technology development.
In vitro studies are also of key importance for increasing
our knowledge about the underlying biological mechanisms
of effects. Interestingly, several of the proteins investigated
in in vitro studies of mechanisms of signal transduction,
have also been observed activated in bronchial biopsies from
human volunteers exposed to diesel exhaust particles in
clinical studies [15, 114, 117, 118]. Thus there is in many cases a
coherence of in vitro and in vivo findings.
With respect to in vitro research on the pulmonary
effects of diesel engine exhaust emissions on inflammatory
reactions, a large diversity of in vitromodels has been applied,
and a range of effect parameters have been investigated. In
addition, several different types of DEP samples have been
used, subjected to different treatments for exposure. The
various models have their advantages and disadvantages, but
the diversity can be seen as strength, though it challenges the
process of generating overall conclusions. Furthermore, for a
complete evaluation of DEP effects also genotoxic and other
outcomes should be taken into consideration.
A well-known limitation of in vitro studies is the gen-
eral use of exposure concentrations that are on the high
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side, compared to real world situations. The exact levels
to which pulmonary cells are likely to be exposed to in
vivo are difficult to estimate, based on the complexity of
the deposition pattern. However, according to estimations
of Li and colleagues, a biologically relevant tissue culture
concentration of DEP ranges from 0.2 to 20 ug/cm2 [119].
Although the concentrations used in several studies fall
within this range, and certain effects also have been detected
at concentrations below this range, it would be important
to optimize and increase the sensitivity of current in vitro
models. Of notice, direct exposure to freshly generated DEP
of cells at the air/liquid interface (ALI) has been performed
[42, 120–122]. Results reported from these rather complicated
models support results obtained by exposing traditional
submerged cell cultures with DEP collected on filters. This
may be due to similar amounts of organic components being
released independently of the aggregation/agglomeration
state. However, some studies suggest that response to ALI
exposure may occur at lower DEP-doses that by conventional
exposure of submerged cell cultures [120–122]. These are
important observations considering that in vitro studies often
are criticized for using too high particle concentrations.
The inflammatory effects of DEP seem to be attributable
to the soluble organic fraction, but questions still remain
with respect to what fraction and components that are most
important for the inflammatory responses. The mechanisms
are still unclear, but receptors in the plasma membrane,
including the PAR-2 receptor, vanilloid-1 receptor, RAGE-
receptor, and the EGF-receptor, seem to be involved. DEP
are known to induce acellular as well as cell-mediated ROS-
formation, oxidative stress and deplete the levels of antioxi-
dants, which seem to be involved in the inflammatory effects
of DEP. At what stage the oxidative tonus exerts its major
effect(s) in the signalling pathways leading to inflammation
remains to be further clarified.
Of notice, engine and fuel technology have been rapidly
changing resulting in reduced emissions. The question arises
whether this reduction in DEP from modern engines has
resulted in an equivalent reduction in harmful properties of
the emissions. Moreover, increased use of biodiesel to meet
demands for CO
2
-neutral fuels warrants further studies on
how different fuels affect the pro-inflammatory properties of
DEP.
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